As of 22 Oct 2026, ABM Respiratory Care has raised $14.8M across 1 verified round on record; latest: $14.8 million Series B led by Peter Soderberg, announced 17 Jun 2025.
2 sources
The source states that Peter Soderberg led the round and identifies him as Managing Partner of Worthy Venture Resources, LLC; it does not call Worthy a lead investor.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B Series B financing round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $14.8M | 2025-06-17 | Peter Soderberg | No recent discussion |
2 sources [ VERIFIED ] read against 1 of 2 sources The source states that Peter Soderberg led the round and identifies him as Managing Partner of Worthy Venture Resources, LLC; it does not call Worthy a lead investor. | ||||
ABM Respiratory Care builds connected airway-clearance and ventilation devices for people with compromised respiratory systems and the healthcare professionals who treat them.
ABM addresses the burden of clearing airway secretions and supporting breathing for patients with compromised respiratory systems by combining therapies in portable BiWaze systems for home and hospital use. Its $14.8 million Series B, following the US$10.3M Series A, is funding U.S. commercialization, clinical research, and patient and digital-health capabilities as it moves a connected respiratory-care platform toward broader adoption.
Checked against 9 sources today
Also named as backers in company research: Advanced MedTech Holdings, SEEDS Capital